Oral SQ House Dust Mite Immunotherapy Reduces Allergic Rhinitis Symptoms in TeensMonthly Prescribing Reference (registration)The oral SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet, an allergy immunotherapy tablet, reduces house dust m… Continue reading
|
How Safe is Subcutaneous and Sublingual Allergen Immunotherapy?
Benzinga The research was presented in the abstract “Evaluation of Risk Factors for Infections and Systemic Reactions (SRs) Associated with Subcutaneous and Sublingual Allergen Immunotherapy (SCIT and SLIT): AAAAI/ACAAI National Surveillance Study … |
|
Oral House Dust Mite Immunotherapy Safe, Effective in Allergic Rhinitis
Monthly Prescribing Reference (registration) ATLANTA, GA—House dust mite (HDM) sublingual immunotherapy (SLIT) tablet (MK-8237, Merck/ALK) offers consistent efficacy and safety among patients with HDM allergic rhinitis, with or without conjunctivitis (AR/C), according to a post-hoc analysis of … |
Benzinga |
Stem cells offering faint cure possibility for glaucoma
ModernMedicine Atlanta — Stem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference. While stem cell therapy is not yet ready for human application, its advancement may … Exclusive: CBMG CEO Talks Stem–Cell Therapies, Cancer Treatments, Financials & The Chinese MarketBenzinga This simple method can predict a stem cell’s fate – FuturityFuturity: Research News Stem cell treatment may restore vision to patients with damaged corneasScienceBlog.com (blog) Diabetes.co.uk –Street Register –Medgadget (blog) all 14 news articles » |
Reading Eagle |
Dr. John Reitz: Preserving stem cells from baby teeth
Reading Eagle Dear Dr. Reitz: My dentist offers a service in which a child’s stem cells are obtained and saved from their baby teeth. The stem cells are frozen, with the potential to cure various systemic diseases that my child may have later in life. Do you know … |
MedCity News |
Why does anybody own CRISPR? An argument against academic IP
MedCity News “I’ve seen many examples, both in companies I’m associated with and other people, of people who could make use of CRISPR in very big and important ways, but are doing other things that are slower, more expensive, less efficient, because they are … |
Latinos Health |
New Type Of Radiation Therapy Gives Hope For The Prevention Of Developing Second Cancer In Children
Latinos Health This is a very effective form of radiotherapy; it utilizes a high-powered beam of protons in replace of the high-energy X-rays. It transported proper doses to the cancerous areas thus it doesn’t hit healthy tissues. Read also gene therapy for blood … |
Drug Discovery & Development |
Advaxis, SELLAS Ink Licensing Agreement for WT1 Antigen-Targeting Immunotherapy
Drug Discovery & Development Advaxis, Inc. and SELLAS Life Sciences Group, both late-stage biopharmaceutical companies focused on developing cancer immunotherapies, today announced that Advaxis has granted SELLAS a license to develop a novel cancer immunotherapy agent … |